Boston, MA -- (SBWIRE) -- 10/25/2016 -- This market report summarizes the results of an industry-wide global web-based benchmarking survey on mass spectrometry (MS) in drug discovery and development carried out in September 2016.

The survey was initiated by the publisher as part of its tracking of emerging life science marketplaces. The questionnaire was compiled to meet the needs, requirements and interests of the mass spectrometry (MS) instruments and assays vendor community. The objective was to comprehensively document the current status and preferences of using MS for drug discovery and development, and to understand future user requirements, particularly with respect to higher throughput screening platforms.

Equal emphasis was given to soliciting opinion from Pharma, Biotech and Academic Research market segments in both North America and Europe.

To view a detailed description and Table of Contents please visit: http://bit.ly/2eMSaWd

The main questionnaire consisted of 28 multi-choice questions and 3 open-ended questions. In addition, there were 6 questions related solely to the administration of survey.

The survey collected 77 validated responses, of these 70% provided comprehensive input.

Survey responses were geographically split: 43% Europe; 36% North America; 13% Asia (excluding Japan & China); 4% Japan; and 4% ROW (rest of World).

Survey respondents were drawn from persons or groups using MS-based assays or approaches in drug discovery and development or planning future investigation in this area.

Respondents represented 34 University/Research Institute/Government Lab/Not-For-Profit; 14 Large Pharma; 8 Medium-Small Pharma; 6 Biotech Company; 5 Biopharma; 4 Contract Research Organisation; 3 Academic Screening Lab; 1 Agrochemical/Agri-Biotech Company; 1 Medical School /Hospital/Clinic; and 1 Other.

Most survey respondents had a senior job role or position which was in descending order: 15 senior scientists/researchers; 13 research scientists; 12 professor/assistant professors; 7 lab managers; 7 directors; 7 principal investigators; 5 section/group leaders; 3 other roles; 2 graduates/PhD students; 2 post-docs; 2 department heads; and 1 vice president.

Survey results were expressed as an average of all survey respondents. In addition, where appropriate the data was reanalyzed after sub-division into the following 5 survey groups: 1) Pharma; 2) Biotech; 3) Academic Research; 4) North America; and 5) Europe.

The full report provides the data, details of the breakdown of the responses to each question, its segmentation and estimates for the future (2018). It also highlights some interesting differences, particularly between Pharma versus the other survey groups.

To enquire about this Report please visit @ http://bit.ly/2eGQAH8

About ReportsWorldwide.com
ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.